[ TRANSACTION RECORD ]

The Carlyle Group Investment in Carlyle Vantive Platform — 2024

VERIFIED VECTOR ID: 002199 · tx-295
M SOURCE NODE — FUNDER
The Carlyle Group
Finance United States
$3,800,000,000
EQUITY
13/08/2024
Q DESTINATION NODE — RECIPIENT
Carlyle Vantive Platform
SPV United States
Amount (USD)
$3.8B
Flow Type
EQUITY
Transaction Date
13/08/2024
Primary Source
View Filing ↗
Funder Profile [ M ]
Entity The Carlyle Group
AUM 426000
HQ Location United States
Sector Finance
Recipient Profile [ Q ]
Entity Carlyle Vantive Platform
Entity Type SPV
Jurisdiction United States
Intelligence Note

The Carlyle Group entered into an agreement to acquire Baxter’s Kidney Care segment, Vantive, for 3.8 billion dollars to establish it as an independent healthcare leader. This transaction provides the necessary capital to scale global renal therapy and hospital solutions. This deal represents a major institutional deployment of capital into the resilient medical device sector.

Σ
Primary Forensic Source https://www.carlyle.com/media-room/news-release-archive/carlyle-to-acquire-baxter-kidney-care-segment/
✓ SOURCE LINKED